Anti-Siglec-3/CD33 Antibody (Vadastuximab talirine)
Catalog No.
F1485
Anti-Siglec-3/CD33 Antibody (Vadastuximab talirine)
Featured Products
Vadastuximab is a targetedHuman monoclonal antibody against CD33, which can be used to synthesize the ADC compound Vadastuximab talirine.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1436390-64-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
SGN-CD33A, 2H12
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P20138
Human,Cynomolgus [US9587019B2]
PBD
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Siglec-3 / CD33
Please avoid freeze-thaw cycles.